Indivior Pharmaceuticals, Inc.

INDV

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001625297

SEC filings (opens in a new tab)

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Indivior Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of INDV: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	103	2	113	+12
Shares	73.0M	166.8K	77.8M	+4.93M (+6.8%)
Value	$720.7M	$1.63M	$974.8M	+$255.7M (+35.6%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to INDV in Q4 2024
Institution	Shares	Value	% of portfolio
Rubric Capital Management LP	1,360,000	$16.9M	0.31%
Weiss Asset Management LP	817,972	$10.2M	0.23%
Claret Asset Management Corp	748,486	$9.30M	1.47%
Foursixthree Capital LP	373,231	$4.64M	4.04%
Gendell Jeffrey L	303,263	$3.77M	0.12%
Prelude Capital Management, LLC	242,546	$3.01M	0.25%
Cubist Systematic Strategies, LLC	218,958	$2.72M	0.04%
SIH Partners, LLLP	217,058	$2.70M	0.19%
Kazazian Asset Management, LLC	133,183	$1.71M	1.34%
Schonfeld Strategic Advisors LLC	135,661	$1.69M	0.01%
BlackRock, Inc.	103,636	$1.29M	0.00%
D. E. Shaw & Co., Inc.	99,606	$1.24M	0.00%
Hennion & Walsh Asset Management, Inc.	95,935	$1.19M	0.05%
Landscape Capital Management, L.L.C.	78,682	$978.0K	0.10%
Evelyn Partners Investment Management Services Ltd	58,149	$722.8K	0.13%
China Universal Asset Management Co., Ltd.	28,906	$359.3K	0.03%
Campbell & CO Investment Adviser LLC	25,391	$325.3K	0.03%
Gotham Asset Management, LLC	26,121	$324.7K	0.00%
JustInvest LLC	14,825	$184.3K	0.00%
Evelyn Partners Investment Management LLP	13,262	$164.8K	0.01%
Pale Fire Capital SE	10,001	$124.3K	0.03%
Simplex Trading, LLC	4,703	$58.0K	0.00%
Lazard Asset Management LLC	4,661	$57.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	4,543	$56.2K	0.00%
GF Fund Management Co. Ltd.	2,862	$35.6K	0.00%
Point72 (DIFC) Ltd	1,461	$18.2K	0.00%
Daiwa Securities Group Inc.	450	$6.00K	0.00%
Caitong International Asset Management Co., Ltd	51	$634	0.00%

Sold out (16)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of INDV in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Norges Bank	2,196,814	$21.6M
Mangrove Partners	1,156,010	$11.3M
Iron Triangle Partners LP	845,470	$8.24M
AlphaCentric Advisors LLC	242,500	$2.36M
Petrus Trust Company, LTA	128,277	$1.25M
Mediolanum International Funds Ltd	124,624	$1.24M
Artemis Investment Management LLP	120,000	$1.18M
Caption Management, LLC	100,309	$978.0K
Centiva Capital, LP	85,090	$829.6K
Voloridge Investment Management, LLC	63,521	$619.3K
Valence8 US LP	57,293	$564.2K
J. Safra Sarasin Holding AG	17,900	$176.8K
AXA S.A.	17,118	$166.9K
Graham Capital Management, L.P.	14,169	$138.1K
NBC Securities, Inc.	470	$4.00K
CVA Family Office, LLC	204	$1.99K

Not filed for Q4 2024 yet (2)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INDV in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Susquehanna International Group Ltd.	127,341	$1.24M
Sage Rock Capital Management LP	39,500	$385.1K